Changes In Magnetic Resonance Imaging Disease Measures Over 3 Years In Mildly Disabled Patients With Relapsing-Remitting Multiple Sclerosis Receiving Interferon Beta-1a In The Cognitive Impairment In Multiple Sclerosis (cogimus) Study
CNR Ibb | back to homepage